LADENBURG THALMANN FINANCIAL SERVICES INC. - ARGOS THERAPEUTICS INC ownership

ARGOS THERAPEUTICS INC's ticker is ARGSXXXX and the CUSIP is 040221103. A total of 22 filers reported holding ARGOS THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of ARGOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$0
-100.0%
2,562
-36.9%
0.00%
Q3 2017$1,0000.0%4,0620.0%0.00%
Q2 2017$1,000
-50.0%
4,0620.0%0.00%
Q1 2017$2,000
-66.7%
4,062
+225.0%
0.00%
Q4 2016$6,0000.0%1,2500.0%0.00%
Q3 2016$6,000
-14.3%
1,2500.0%0.00%
Q2 2016$7,000
+75.0%
1,250
+78.6%
0.00%
Q1 2016$4,0007000.00%
Other shareholders
ARGOS THERAPEUTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
SANDERS MORRIS HARRIS LLC 241,512$1,201,0000.36%
WALL STREET ASSOCIATES 185,097$920,0000.31%
WASATCH ADVISORS LP 3,228,741$16,047,0000.24%
ALTRINSIC GLOBAL ADVISORS LLC 172,505$857,0000.03%
Dynamic Technology Lab Private Ltd 19,007$94,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 121,524$604,0000.01%
Alyeska Investment Group, L.P. 200,000$994,0000.01%
Acrospire Investment Management LLC 2,100$10,0000.01%
Alyeska Investment Group, L.P. 111,424$554,0000.01%
Advisor Group, Inc. 13,500$67,0000.00%
View complete list of ARGOS THERAPEUTICS INC shareholders